• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强直性脊柱炎和类风湿关节炎患者外周血Th17细胞的频率及表型

Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis.

作者信息

Shen Hui, Goodall Jane C, Hill Gaston J S

机构信息

University of Cambridge, Department of Medicine, and Addenbrooke's Hospital, Cambridge, UK.

出版信息

Arthritis Rheum. 2009 Jun;60(6):1647-56. doi: 10.1002/art.24568.

DOI:10.1002/art.24568
PMID:19479869
Abstract

OBJECTIVE

To analyze the frequency, surface phenotype, and cytokine secretion of CD4+ T cells in peripheral blood mononuclear cells (PBMCs) from patients with ankylosing spondylitis (AS) compared with both healthy control subjects and patients with rheumatoid arthritis (RA).

METHODS

Eight-color flow cytometry was used to analyze the surface phenotype and cytokine production of PBMCs from 20 patients with AS, 12 patients with RA, and 16 healthy control subjects, following stimulation ex vivo with phorbol myristate acetate and ionomycin for 5 hours. Secretion of interleukin-17 (IL-17) by PBMCs was measured by enzyme-linked immunosorbent assay, following stimulation with anti-CD3/CD28 for 4 days.

RESULTS

The percentages of IL-17-positive CD4+ T cells and IL-22-positive CD4+ T cells were increased in the PBMCs of both patients with AS and patients with RA compared with healthy control subjects, whereas there were no differences in the percentages of interferon-gamma (IFNgamma)-positive or IL-10-positive CD4+ T cells. Likewise, concentrations of IL-17 in supernatants from patients with AS were significantly higher compared with those from healthy control subjects. In patients with RA, the concentrations of IL-17 were increased but not significantly. There was a correlation between the percentages of IL-17-positive CD4+ T cells detected in PBMCs and the amounts of IL-17 in culture supernatants (r=0.414, P=0.0034). All IL-17-producing cells were CD4+CD45RO+; most expressed both CCR6 and CCR4, but only 50% expressed the IL-23 receptor (IL-23R). Nevertheless, there was a positive relationship between the percentage of IL-23R-positive CD4+ T cells and the frequency of IL-17-positive CD4+ T cells or IL-22-positive CD4+ T cells (r=0.57, P<0.0001 and r=0.46, P=0.001, respectively). A significant proportion of cells that produced IL-17 also produced IL-22 and IFNgamma, but none produced IL-10.

CONCLUSION

The frequencies of IL-17-positive and IL-22-positive CD4+ T cells were increased in PBMCs from patients with AS and patients with RA, resulting in secretion of higher quantities of IL-17 by PBMCs following stimulation. These data support the hypothesis that Th17 cells, particularly when present in excess of IL-10-producing cells, are involved in the pathogenesis of inflammatory arthritis.

摘要

目的

分析强直性脊柱炎(AS)患者外周血单个核细胞(PBMC)中CD4⁺T细胞的频率、表面表型及细胞因子分泌情况,并与健康对照者和类风湿关节炎(RA)患者进行比较。

方法

采用八色流式细胞术分析20例AS患者、12例RA患者和16例健康对照者的PBMC经佛波酯肉豆蔻酸酯乙酸盐和离子霉素体外刺激5小时后的表面表型及细胞因子产生情况。用酶联免疫吸附测定法检测PBMC经抗CD3/CD28刺激4天后白细胞介素-17(IL-17)的分泌情况。

结果

与健康对照者相比,AS患者和RA患者PBMC中IL-17阳性CD4⁺T细胞和IL-22阳性CD4⁺T细胞的百分比均升高,而干扰素-γ(IFNγ)阳性或IL-10阳性CD4⁺T细胞的百分比无差异。同样,AS患者上清液中IL-17的浓度显著高于健康对照者。RA患者中IL-17的浓度升高但不显著。PBMC中检测到的IL-17阳性CD4⁺T细胞百分比与培养上清液中IL-17的量之间存在相关性(r=0.414,P=0.0034)。所有产生IL-17的细胞均为CD4⁺CD45RO⁺;大多数细胞同时表达CCR6和CCR4,但只有50%表达白细胞介素-23受体(IL-23R)。然而,IL-23R阳性CD4⁺T细胞百分比与IL-17阳性CD4⁺T细胞或IL-22阳性CD4⁺T细胞频率之间存在正相关(分别为r=0.57,P<0.0001和r=0.46,P=0.001)。相当一部分产生IL-17的细胞也产生IL-22和IFNγ,但均不产生IL-10。

结论

AS患者和RA患者PBMC中IL-17阳性和IL-22阳性CD4⁺T细胞的频率升高,导致PBMC刺激后分泌更多的IL-17。这些数据支持Th17细胞,特别是当其数量超过产生IL-10的细胞时,参与炎症性关节炎发病机制的假说。

相似文献

1
Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis.强直性脊柱炎和类风湿关节炎患者外周血Th17细胞的频率及表型
Arthritis Rheum. 2009 Jun;60(6):1647-56. doi: 10.1002/art.24568.
2
1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis.1,25-二羟基维生素D3调节早期类风湿性关节炎患者记忆T细胞的Th17极化和白细胞介素-22表达。
Arthritis Rheum. 2010 Jan;62(1):132-42. doi: 10.1002/art.25043.
3
Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.通过流式细胞术分析类风湿关节炎中表达CD4 +和CD8 + T细胞的Th1和Th2细胞因子
J Rheumatol. 2000 May;27(5):1128-35.
4
Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis.活动性强直性脊柱炎患者循环中分泌白细胞介素-17的白细胞介素-23受体阳性γ/δT细胞增多。
Arthritis Rheum. 2012 May;64(5):1420-9. doi: 10.1002/art.33507.
5
Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis.阿托伐他汀对类风湿关节炎患者外周血单个核细胞及滑膜成纤维细胞的抗炎作用。
Scand J Rheumatol. 2009;38(4):235-9. doi: 10.1080/03009740802572475.
6
Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis.类风湿关节炎患者滑膜组织和外周血中CD4⁺T细胞产生细胞因子的流式细胞术单细胞分析。
Arthritis Rheum. 1998 Sep;41(9):1669-76. doi: 10.1002/1529-0131(199809)41:9<1669::AID-ART19>3.0.CO;2-G.
7
Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides.血清阴性脊柱关节炎患者循环中多功能Th17记忆细胞数量增加。
Arthritis Rheum. 2008 Aug;58(8):2307-17. doi: 10.1002/art.23655.
8
Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.调节性CD4 + T细胞亚群的表达降低与类风湿关节炎中的Th1/Th2平衡及疾病严重程度相关。
Arthritis Rheum. 2000 Mar;43(3):617-27. doi: 10.1002/1529-0131(200003)43:3<617::AID-ANR19>3.0.CO;2-B.
9
Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.英夫利昔单抗治疗强直性脊柱炎期间非特异性和抗原特异性T细胞细胞因子反应的下调
Arthritis Rheum. 2003 Mar;48(3):780-90. doi: 10.1002/art.10847.
10
IL-22+ CD4+ T cells in patients with rheumatoid arthritis.类风湿关节炎患者中的 IL-22+ CD4+ T 细胞。
Int J Rheum Dis. 2013 Oct;16(5):518-26. doi: 10.1111/1756-185X.12099. Epub 2013 Jun 10.

引用本文的文献

1
Bimekizumab in the Treatment of Axial Spondyloarthritis and Psoriatic Arthritis: A New Kid on the Block.比美吉珠单抗治疗中轴型脊柱关节炎和银屑病关节炎:初来乍到的新药物
Int J Mol Sci. 2025 Mar 5;26(5):2315. doi: 10.3390/ijms26052315.
2
The Significance of the Cell-Mediated Host Immune Response in Syphilis.细胞介导的宿主免疫反应在梅毒中的意义。
Microorganisms. 2024 Dec 13;12(12):2580. doi: 10.3390/microorganisms12122580.
3
Investigating potential novel therapeutic targets and biomarkers for ankylosing spondylitis using plasma protein screening.
利用血浆蛋白质筛选技术,探索强直性脊柱炎潜在的新型治疗靶点和生物标志物。
Front Immunol. 2024 Aug 9;15:1406041. doi: 10.3389/fimmu.2024.1406041. eCollection 2024.
4
Crosstalk between Inflammation and Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Is There a Common Basis?类风湿关节炎和系统性红斑狼疮中炎症与动脉粥样硬化的相互作用:是否存在共同基础?
Life (Basel). 2024 May 31;14(6):716. doi: 10.3390/life14060716.
5
Pharmacokinetics, Safety, and Immunogenicity of Intravenous and Subcutaneous Single-Dose QX002N Injection in Healthy Subjects: A Randomized, Open, Parallel, Single-Center, Phase I Study.健康受试者静脉和皮下单剂量注射QX002N的药代动力学、安全性及免疫原性:一项随机、开放、平行、单中心的I期研究
Rheumatol Ther. 2024 Aug;11(4):977-988. doi: 10.1007/s40744-024-00683-0. Epub 2024 Jun 9.
6
Increased interleukin-26 in the peripheral joints of patients with axial spondyloarthritis and psoriatic arthritis, co-localizing with CD68-positive synoviocytes.在患有中轴型脊柱关节炎和银屑病关节炎的患者外周关节中,白细胞介素-26 增加,并与 CD68 阳性的滑膜细胞共定位。
Front Immunol. 2024 May 10;15:1355824. doi: 10.3389/fimmu.2024.1355824. eCollection 2024.
7
Axial Spondyloarthritis: an overview of the disease.轴性脊柱关节炎:疾病概述
Rheumatol Int. 2024 Sep;44(9):1607-1619. doi: 10.1007/s00296-024-05601-9. Epub 2024 Apr 30.
8
Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial.基于炎症客观指标探索司库奇尤单抗对强直性脊柱炎患者疼痛的影响:一项大型随机临床试验的事后分析
Rheumatol Ther. 2024 Jun;11(3):691-707. doi: 10.1007/s40744-024-00660-7. Epub 2024 Apr 18.
9
The Efficacy and Safety of Biologics in Treating Ankylosing Spondylitis and Their Impact on Quality of Life and Comorbidities: A Literature Review.生物制剂治疗强直性脊柱炎的疗效与安全性及其对生活质量和合并症的影响:一项文献综述
Cureus. 2024 Mar 3;16(3):e55459. doi: 10.7759/cureus.55459. eCollection 2024 Mar.
10
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials.在银屑病、银屑病关节炎或中轴型脊柱关节炎患者中的长期安全性:来自 25 项随机临床试验的最终安全性数据的事后分析。
Arthritis Res Ther. 2024 Feb 12;26(1):49. doi: 10.1186/s13075-023-03257-7.